ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸

KLRS // Kalaris Therapeutics Inc.

DIV <GO> NASDAQ RQD COCKPIT → CIK 0001754068 ↗
Health Care • Biotechnology: Biological Products (No Diagnostic Substances)
$2.13 ▲ +0.12 (+5.97%)
MKT CAP: $50.7M • VOL: 23.2K
CASH DIVIDEND YIELD
0.00%
ANNUAL RATE: $0.00 / SH
TOTAL SHAREHOLDER YIELD
1.85%
BUYBACK YIELD: 1.85%
FCF PAYOUT COVERAGE RATIO
0.0%
GAAP EPS PAYOUT: 0.0%
DIVIDEND SAFETY SCORE NO DIVIDEND
50/100
GROWTH STREAK: 0 CONSECUTIVE YRS
KLRS // EX-DIVIDEND & CAPITAL DISTRIBUTION SCHEDULE (DIV <GO>) SPOT: $2.13
Kalaris Therapeutics Inc. (KLRS) DOES NOT CURRENTLY DISTRIBUTE A REGULAR CASH DIVIDEND. CAPITAL ALLOCATION PRIORITIZES INTERNAL R&D (-35.0% ROIC) AND OPPORTUNISTIC SHARE REPURCHASES (1.85% BUYBACK YIELD).